BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1894469)

  • 1. Coryneform group A-4 endophthalmitis. An experimental animal model.
    McManaway JW; Weinberg RS; Coudron PE
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2696-9. PubMed ID: 1894469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
    Bucher RS; Hall E; Reed DM; Richards JE; Johnson MW; Zacks DN
    Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes.
    Lieb DF; Scott IU; Flynn HW; Miller D; Feuer WJ
    Ophthalmology; 2003 Aug; 110(8):1560-6. PubMed ID: 12917173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis.
    Liu F; Kwok AK; Cheung BM
    Curr Eye Res; 2008 Sep; 33(9):761-8. PubMed ID: 18798079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
    Hosseini H; Mehryar M; Eghtedari M; Ahmadi F; Nowroozizadeh S
    Curr Eye Res; 2009 Feb; 34(2):145-51. PubMed ID: 19219686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative Corynebacterium macginleyi endophthalmitis.
    Ferrer C; Ruiz-Moreno JM; Rodríguez A; Montero J; Alió JL
    J Cataract Refract Surg; 2004 Nov; 30(11):2441-4. PubMed ID: 15519105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
    Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of intravitreal piperacillin/tazobactam with ceftazidime in experimental Pseudomonas aeruginosa endophthalmitis.
    Ozkiriş A; Evereklioglu C; Akgün H; Eşel D; Caner F; Erkiliç K
    Exp Eye Res; 2005 Mar; 80(3):361-7. PubMed ID: 15721618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous imipenem prophylaxis in experimental endophthalmitis.
    Miño de Kaspar H; Engelbert M; Thiel M; Grasbon T; Ta CN; Klauss V; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):557-64. PubMed ID: 12136287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cultures on management decisions following surgical repair of penetrating ocular trauma.
    Rubsamen PE; Cousins SW; Martinez JA
    Ophthalmic Surg Lasers; 1997 Jan; 28(1):43-9. PubMed ID: 9031304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolates and antibiotic sensitivity of eighty culture-proven endophthalmitis cases from Istanbul.
    Eser I; Kapran Z; Altan T; Ozel Karatas M; Aydin D; Okaygun E; Yilmaz OF
    Ophthalmologica; 2008; 222(3):157-60. PubMed ID: 18497523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of secreted proteases to the pathogenesis of postoperative Enterococcus faecalis endophthalmitis.
    Suzuki T; Wada T; Kozai S; Ike Y; Gilmore MS; Ohashi Y
    J Cataract Refract Surg; 2008 Oct; 34(10):1776-84. PubMed ID: 18812133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
    De Kaspar HM; Ta CN; Engelbert M; Mette M; Thiel M; Kampik A
    Retina; 2008 Feb; 28(2):326-32. PubMed ID: 18301039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains.
    Jett BD; Jensen HG; Atkuri RV; Gilmore MS
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):9-15. PubMed ID: 7822163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis.
    McCormick CC; Dajcs JJ; Reed JM; Marquart ME; O'Callaghan RJ
    Curr Eye Res; 2006 Mar; 31(3):225-30. PubMed ID: 16531279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endophthalmitis caused by Haemophilus influenzae.
    Yoder DM; Scott IU; Flynn HW; Miller D
    Ophthalmology; 2004 Nov; 111(11):2023-6. PubMed ID: 15522367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of blood on susceptibility to Staphylococcal endophthalmitis.
    Wells EJ; Franco LM; Price CT; Graham JE; Barr CC
    Retina; 2007 Oct; 27(8):1125-30. PubMed ID: 18040257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endophthalmitis caused by Serratia marcescens.
    Cohen SM; Flynn HW; Miller D
    Ophthalmic Surg Lasers; 1997 Mar; 28(3):195-200. PubMed ID: 9076792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.
    Deng SX; Penland S; Gupta S; Fiscella R; Edward DP; Tessler HH; Goldstein DA
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1516-21. PubMed ID: 16565387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenotrophomonas maltophilia Endophthalmitis after cataract extraction.
    Karakurt A; Abdik O; Sengün A; Karadağ R; Saricaoğlu S; Sarikatipoğlu HY; Hasiripi H
    Ocul Immunol Inflamm; 2006 Feb; 14(1):41-6. PubMed ID: 16507490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.